19,190 results match your criteria: "American journal of respiratory and critical care medicine[Journal]"
Am J Respir Crit Care Med
December 2024
University of Insubria, Varese, Italy.
Am J Respir Crit Care Med
December 2024
NIH, National Heart, Lung, and Blood Institute, Bethesda, Maryland, United States.
Am J Respir Crit Care Med
December 2024
Radboud University Medical Center, Intensive care medicine, Nijmegen, Netherlands.
Am J Respir Crit Care Med
December 2024
Loyola University Chicago Stritch School of Medicine, Pulmonary and Critical Care, Maywood, Illinois, United States.
Am J Respir Crit Care Med
December 2024
University of Pennsylvania, Schools of Medicine and Nursing, Philadelphia, Pennsylvania, United States.
Am J Respir Crit Care Med
December 2024
University of Southampton Faculty of Medicine, Clinical & Experimental Sciences, Southampton, United Kingdom of Great Britain and Northern Ireland;
Am J Respir Crit Care Med
December 2024
University of Minnesota, Minneapolis , Minnesota, United States;
Am J Respir Crit Care Med
December 2024
Centre Hospitalier Universitaire de Poitiers, Médecine Intensive Réanimation, Poitiers, France.
Am J Respir Crit Care Med
December 2024
Shanxi Bethune Hospital, Shanxi Academy of Medical Sciences, Third Hospital of Shanxi Medical University, Tongji Shanxi Hospital, Taiyuan, 030032, China.
Am J Respir Crit Care Med
December 2024
University of Pittsburgh, Pediatric Pulmonary Medicine, Pittsburgh, Pennsylvania, United States.
Am J Respir Crit Care Med
December 2024
University of Ottawa, Department of Medicine, Division of Palliative Care, Ottawa, Canada.
Am J Respir Crit Care Med
December 2024
University of Exeter Medical School, University of Exeter, Exeter, United Kingdom of Great Britain and Northern Ireland.
Chronic obstructive pulmonary disease (COPD) is a heterogenous lung condition characterized by progressive airflow obstruction. Despite advancements in diagnosis and treatment, the disease burden remains high; although clinical trials have shown improvements in outcomes such as exacerbations, quality of life, and lung function, improvement may not be attainable for many patients. For patients who do experience improvement, it is challenging to set management goals given the progressive nature of COPD.
View Article and Find Full Text PDFAm J Respir Crit Care Med
December 2024
Hines VA Hospital, Pulmonary and Critical Care Medicine, Hines, Illinois, United States.
Rationale: No systematic investigation into dyspnea in patients receiving prolonged ventilation (>21 days) after recovering from critical-illness has been published.
Objectives: To determine magnitude, nature and pathophysiological basis of dyspnea during an unassisted-breathing trial in prolonged-ventilation patients.
Methods: Dyspnea intensity and descriptor selection were investigated in 27 prolonged-ventilation patients during a 60-min unassisted-breathing trial.
Am J Respir Crit Care Med
December 2024
APHP, Groupe Hospitalier Pitie Salpêtrière, Medecine intensive Reanimation, Paris, France.
Rationale: High flow therapy reduces dyspnea in acute respiratory failure but the underlying mechanisms are not fully elucidated.
Objectives: To compare dyspnea, airway occlusion pressure (P) and inspiratory work with and without nasal high flow (NHF, FiO 21%, temperature 31°C) in intubated patients under pressure support ventilation and during a spontaneous breathing trial (SBT).
Methods: Dyspnea (numerical rating scale, NRS and Mechanical Ventilation - Respiratory Distress Observational Scale, MV-RDOS), P, esophageal pressure, respiratory muscles EMG, arterial blood gas were compared in intubated patients on pressure support ventilation presenting a dyspnea-NRS > 3 during two sequences: 1) pressure support ventilation with NHF at 0 L/min followed by 30, 50 and 60 L/min (the last three were randomized) and 2) a SBT with NHF at 0 and 50 L/min (randomized).
Am J Respir Crit Care Med
December 2024
University of Cape Town Desmond Tutu HIV Centre, Observatory, South Africa.
Am J Respir Crit Care Med
December 2024
Cleveland Clinic, Respiratory Institute, Cleveland, Ohio, United States.
Am J Respir Crit Care Med
December 2024
University of Michigan, Pulmonary and Critical Care Medicine, Ann Arbor, Michigan, United States.
Am J Respir Crit Care Med
December 2024
Imperial College London National Heart and Lung Institute, Airways disease, London, United Kingdom of Great Britain and Northern Ireland;
Rationale: Unrecognised coronary artery disease (CAD) may contribute to adverse outcomes in chronic obstructive pulmonary disease (COPD). Improved identification of at-risk groups could inform better preventative care. We aimed to evaluate the burden and relationships of radiologically detectable CAD in COPD, establish frequency of occult disease, and examine potential cardiovascular screening methods.
View Article and Find Full Text PDFAm J Respir Crit Care Med
December 2024
Am J Respir Crit Care Med
December 2024
China-Japan Friendship Hospital Department of Radiology, Beijing, China;
Am J Respir Crit Care Med
December 2024
University of California, San Francisco, Division of Pulmonary and Critical Care Medicine, San Francisco, United States.
: C-reactive protein (CRP)-based tuberculosis (TB) screening is recommended for people with HIV (PWH). However, its performance among people without HIV and in diverse settings is unknown. : In a multi-country study, we aimed to determine whether CRP meets the minimum accuracy targets (sensitivity ≥90%, specificity ≥70%) for an effective TB screening test.
View Article and Find Full Text PDFAm J Respir Crit Care Med
December 2024
University of Alabama at Birmingham, Division of Pulmonary and Critical Care Medicine, Birmingham, Alabama, United States;
Am J Respir Crit Care Med
December 2024
Guiqian International General Hospital, Department of Pathology, Guiyang, Guizhou, China;
Am J Respir Crit Care Med
December 2024
St Michael's Hospital in Toronto, Li Ka Shing Knowledge Institute, Keenan Research Centre, Toronto, Canada.
Am J Respir Crit Care Med
December 2024
Bloomsbury Institute of Intensive Care Medicine, London, United Kingdom of Great Britain and Northern Ireland;